TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen - Wikidata - wikimedia - TriplyDB

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

http://www.wikidata.org/entity/Q35140137

about

Effect of TACI signaling on humoral immunity and autoimmune diseases Harnessing B cells in immunotherapy TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.The Role of BAFF System Molecules in Host Response to Pathogens.Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.Mapping protective regions on a three-dimensional model of the Moraxella catarrhalis vaccine antigen, Oligopeptide Permease A.Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.TACI Isoforms Regulate Ligand Binding and Receptor Function

P2860

Q26995571-0D289D49-DD24-4A17-81A3-30AB42515738 Q28066838-708EBBEA-AE3A-4EAC-9CB7-164F1257C51E Q35910201-ED4EF0BB-3FC9-4807-A475-59D0A9EE4CF9 Q38601694-BF3AFC78-0C1B-464F-BD05-B58787BF2BEF Q40546259-CBEB833A-6DB2-41A3-9B52-59B306B0B6C9 Q47332587-32A0BB19-55CC-4F1A-A5E7-E942389C4594 Q49808758-432147FD-5ED0-4058-BF8C-5B73FCABB2E8 Q58586489-C0A43218-DCB3-4B86-8510-D6F5FCC2CF34

P2860

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

http://www.wikidata.org/entity/Q35140137

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@ast

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@en

type

label

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@ast

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@en

prefLabel

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@ast

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@en

P1433

Q35140137-CC082A42-7F85-43B3-8D5F-06C9E3532F3B

P1476

Q35140137-5653AA15-DB30-4FA5-A4D3-1306EA88A33C

P2093

Q35140137-63DE398D-82D2-43EA-8D90-CF7567CC93E6

Q35140137-6A03B950-AFCF-4825-AB44-9DA20D4B90C9

Q35140137-D2682838-D617-4128-BA54-6975B1CEA575

Q35140137-DDB91E9B-EFCD-41E4-92CA-BD92E605D6E6

Q35140137-ECE0C7D0-01A7-460F-BD16-8AC6A09D7945

Q35140137-F9C6A61B-7952-4343-920A-ADA45C3A649E

P2860

Q35140137-0455DF4E-1E7E-4997-91CB-C0753EF934FB

Q35140137-062CDF83-C47B-4AA9-9F95-65D63AAC5E91

Q35140137-0F615F1C-3C1D-4E41-881A-3A6B188F5FA7

Q35140137-14C89064-DF31-4491-95EC-FD335E8138E6

Q35140137-17A69E37-789F-4047-AB7D-5976AA78153D

Q35140137-1B9BE7B1-F8E1-43E8-9DB0-5465C836378B

Q35140137-27A91C98-BB04-4B80-9E5B-F14B3612131F

Q35140137-28A2B397-5184-4FA2-AF44-F6CEB246C534

Q35140137-30D762E8-24AD-4DA4-9542-BFCE380A0B4C

Q35140137-315722AC-159B-4724-8533-22E902887C40

P304

Q35140137-71917E16-2F60-4790-B100-BA4CE08DB2A6

P31

Q35140137-B1932438-C0E2-4DBD-A893-7F1C466F1AFF

P356

Q35140137-431DEC8A-F0F6-4348-B762-6DA7024FF241

P407

Q35140137-637CDDCA-F37C-424A-865A-72610CB404F6

P433

Q35140137-2585D3D0-F577-45F6-B737-D810DB12AAFD

P478

Q35140137-13FEB20E-9C4F-49DA-9E66-AFD0D9709C96

P50

Q35140137-7E4D07B6-59B1-4122-9238-2F38A384F87D

Q35140137-82D67EA2-AEC5-4602-9ECE-A0BCC4309BD8

Q35140137-E91E5C20-F33A-4931-A7D9-914D17EF5F3E

P577

Q35140137-65968227-4384-4ED2-BFD3-4AE78504BF2E

P5875

Q35140137-1F7AFA8B-C2F9-430E-97CE-C5490CFE5A8B

P698

Q35140137-29F898FD-45B4-4509-B107-60F3385762DC

P932

Q35140137-70DDAE70-036B-4B21-9C35-A3AE60915E9B

P356

P1433

Journal of Clinical Investigation

P1476

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

@en

P2093

Gabriel Nuñez

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Platt

http://www.w3.org/2001/XMLSchema#string

Lucas Stein

http://www.w3.org/2001/XMLSchema#string

Marilia Cascalho

http://www.w3.org/2001/XMLSchema#string

Richard Bram

http://www.w3.org/2001/XMLSchema#string

Shoichiro Tsuji

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated map of genetic variation from 1,092 human genomes

NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily

IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes

TACI is mutant in common variable immunodeficiency and IgA deficiency

Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen

B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity

Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI

CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric series

CSAR data set release 2012: ligands, affinities, complexes, and docking decoys

Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium

P304

4857-4866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI74428

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Bruce A. Vallance

Nobuhiko Kamada

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266380670

http://www.w3.org/2001/XMLSchema#string

P698

25271628

http://www.w3.org/2001/XMLSchema#string

P932

4347253

http://www.w3.org/2001/XMLSchema#string